Hayfin Capital Management

HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

MolecuLight specializes in innovative imaging solutions for wound care, particularly in the detection of harmful bacteria and the measurement of wounds. The company develops portable handheld optical imaging devices that allow medical practitioners to visualize bacteria and assess tissue viability at the point of care. These devices facilitate the documentation and monitoring of wound healing progress, enabling healthcare professionals to select the appropriate therapy for their patients in a timely manner. By providing accurate analysis and procedural guidance, MolecuLight's technology aims to enhance patient outcomes in wound management.

Cosette Pharmaceuticals is a specialized generic pharmaceutical company focusing on dermatology and allergy treatments. It offers a diverse portfolio of branded pharmaceuticals, primarily targeting women's health and cardiology, alongside its core dermatology products. The company's product range includes creams, ointments, lotions, solutions, gels, pastes, suppositories, and oral liquids. With comprehensive capabilities in product development and commercial operations, Cosette Pharmaceuticals aims to effectively meet the drug needs of clients in the dermatology and allergy sectors.

Xeris Biopharma Holdings is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for patients in endocrinology, neurology, and gastroenterology. The company utilizes its proprietary formulation technologies, XeriSol and XeriJect, to create ready-to-use, liquid-stable injectables that facilitate subcutaneous and intramuscular delivery of various therapeutic agents. Xeris offers three commercially available products: Gvoke, a liquid glucagon for severe hypoglycemia; Keveyis, the first FDA-approved treatment for primary periodic paralysis; and Recorlev, approved for endogenous hypercortisolemia in adults with Cushing's Syndrome. Xeris Biopharma's formulation platforms aim to improve patient and caregiver ease of use by eliminating reconstitution, ensuring long-term stability at room temperature, and reducing injection volume, thereby enhancing healthcare delivery and potentially lowering costs for the healthcare system. The company is also advancing a pipeline of development programs to expand its product offerings.

HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

KEO World is a FinTech company based in Miami, Florida, that specializes in all-digital inventory financing and B2B payment solutions. The company aims to support buyers and suppliers in accelerating their business growth through innovative financial services. KEO World operates in the United States, Mexico, and throughout Latin America via its Global Trade program. Utilizing artificial intelligence and machine learning, KEO's platform analyzes banking transactional data to provide potential customers with rapid access to maximum funding. This approach enables businesses and consumers to secure instant financial support, streamlining the financing process and enhancing overall operational efficiency.

ADMA Biologics, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing specialty plasma-derived biologics aimed at treating immune deficiencies and infectious diseases in the United States. The company offers a range of products, including BIVIGAM and ASCENIV, both intravenous immune globulin therapies for primary humoral immunodeficiency, as well as Nabi-HB, which is used for acute exposure to Hepatitis B. ADMA is also involved in the development of additional plasma-derived therapeutics, particularly targeting infections like S. pneumonia. To support its operations, the company runs FDA-licensed source plasma collection facilities known as ADMA BioCenters, which contribute to the supply of plasma necessary for its product manufacturing. ADMA Biologics distributes its products through independent distributors, sales agents, specialty pharmacies, and other healthcare providers. Founded in 2004 and based in Ramsey, New Jersey, ADMA is dedicated to serving niche patient populations, particularly those with compromised immune systems.

KEO World is a FinTech company based in Miami, Florida, that specializes in all-digital inventory financing and B2B payment solutions. The company aims to support buyers and suppliers in accelerating their business growth through innovative financial services. KEO World operates in the United States, Mexico, and throughout Latin America via its Global Trade program. Utilizing artificial intelligence and machine learning, KEO's platform analyzes banking transactional data to provide potential customers with rapid access to maximum funding. This approach enables businesses and consumers to secure instant financial support, streamlining the financing process and enhancing overall operational efficiency.

Avadim Health is a healthcare and wellness company based in Asheville, North Carolina, specializing in the development, manufacturing, and marketing of topical products for both institutional care and consumer markets. Utilizing its Bionome Engineered Platform, the company focuses on enhancing topical immune health, neuromuscular health, and skin barrier health. Avadim Health offers a range of products designed to alleviate pain, infections, muscle cramps, spasms, symptoms of restless leg syndrome, and joint discomfort. These products are distributed to various retail outlets, including grocery stores and pharmacies, as well as acute-care hospitals, nursing homes, and other long-term care facilities. Additionally, the company provides consulting services and sells its products online. Founded in 2007 and initially known as Avadim Technologies, the company rebranded to Avadim Health in September 2018.

Frans Bonhomme is a distributor based in Joué-lès-Tours, France, specializing in a comprehensive range of products for plumbing, heating, and sanitation. The company offers an extensive selection of PVC and polyethylene pipes and fittings, as well as cast iron networks, corrugated pipes, manholes, and stools. In addition to these products, Frans Bonhomme provides equipment for wastewater management, rainwater collection, drainage solutions, and various network accessories. Their offerings cater primarily to the water supply sector, addressing needs in drainage, drinking water, rainwater, and wastewater markets. Through its diverse product range, Frans Bonhomme is committed to delivering quality solutions that meet the demands of both residential and commercial applications.

Amicus Therapeutics, Inc. is a biotechnology company dedicated to the discovery, development, and commercialization of therapies for rare and orphan diseases. Founded in 2002 and headquartered in Cranbury, New Jersey, the company focuses on developing innovative treatments, including Galafold, an orally administered pharmacological chaperone for Fabry disease. Amicus is also advancing its pipeline with a Phase 3 clinical study of AT-GAA for Pompe disease. The company's research includes a range of first-in-class small molecules designed to treat lysosomal storage diseases by stabilizing misfolded enzymes in patients. This therapeutic approach potentially enhances the effectiveness of enzyme replacement therapies. Amicus Therapeutics has established collaborations with institutions such as Nationwide Children's Hospital and the University of Pennsylvania to further its research and development efforts.

MiMedx Group, Inc. is a biopharmaceutical company based in Marietta, Georgia, focused on developing and marketing regenerative biologics derived from human placental tissue allografts. Utilizing its proprietary PURION Process, the company employs aseptic processing techniques and terminal sterilization to create a range of allografts. Key products include EpiFix, a membrane designed for chronic wound treatment, and AmnioFix, which is used in surgical procedures. Other offerings consist of AmnioCord and EpiCord, dehydrated human umbilical cord allografts, and AmnioFill, a connective tissue matrix. MiMedx's products cater to various healthcare sectors, including wound care, burns, surgical applications, orthopedics, sports medicine, ophthalmics, and dentistry. The company distributes its products through a direct sales force, independent agents, and third-party representatives.

GC Aesthetics is a company focused on female aesthetics, specializing in the development, manufacturing, and commercialization of silicone breast implants. The company offers a variety of surgical implants and tissue expanders that provide surgeons with options for breast augmentation, aesthetic enhancement, and reconstructive surgery. Additionally, GC Aesthetics develops silicone products for scar management, including a product line designed to improve the appearance of scars. The company also supports patients and surgeons through educational resources and a patient generator program known as Business Boost. With its headquarters in Dublin, Ireland, and manufacturing facilities located in Scotland, England, and France, GC Aesthetics serves both local and international markets, emphasizing innovation and quality to enhance the body transformation journey for women. Established in 2015, the company leverages over 30 years of industry experience to empower individuals and promote confidence in their aesthetic choices.

Avadim Health is a healthcare and wellness company based in Asheville, North Carolina, specializing in the development, manufacturing, and marketing of topical products for both institutional care and consumer markets. Utilizing its Bionome Engineered Platform, the company focuses on enhancing topical immune health, neuromuscular health, and skin barrier health. Avadim Health offers a range of products designed to alleviate pain, infections, muscle cramps, spasms, symptoms of restless leg syndrome, and joint discomfort. These products are distributed to various retail outlets, including grocery stores and pharmacies, as well as acute-care hospitals, nursing homes, and other long-term care facilities. Additionally, the company provides consulting services and sells its products online. Founded in 2007 and initially known as Avadim Technologies, the company rebranded to Avadim Health in September 2018.

Kingsland Capital is an employee-owned investment manager that specializes in managing investment portfolios focused on fixed income markets. The firm provides services to funds and collateralized loan obligations, primarily investing in corporate debt securities, high yield bonds, distressed assets, and leveraged loans. Kingsland Capital employs a combination of fundamental and technical analysis to develop its investment strategies and create diversified portfolios that effectively address the complexities of high yield, leveraged, and distressed asset classes.

NKD Group is a retailer specializing in textiles and home accessories, providing a diverse range of products for households, teenagers, and the sports sector. The company offers fashionable apparel for men, women, and children, including dresses, blouses, trousers, and jackets, catering to various tastes and fashion trends. In addition to clothing, NKD provides functional sportswear and home textiles, along with seasonal decoration items. The company's offerings are available through both online and offline stores, ensuring customers have access to a wide selection of affordable fashion and essential home goods. Regular updates to their inventory include seasonal novelties and trendy items, making NKD a comprehensive destination for contemporary fashion and home accessories.

Novetude Santé Group is a French organization that operates a network of higher education institutions focused on training healthcare professionals. Established in 2009 and headquartered in Paris, the group provides a range of educational services. Its offerings include preparatory classes for medical and paramedical exams, diploma courses in osteopathy, and vocational training in fields such as optics, dietetics, social and family economy, prosthetics, and dental assistance. Additionally, Novetude Santé Group emphasizes continuing education to enhance the skills of health professionals, ensuring they remain updated with the latest practices and knowledge in their respective fields.